Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-29

Clinical Trial Update: Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral branched-chain amino acid supplementation in patients with decompensated cirrhosis and ascites; currently enrolling by in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral branched-chain amino acid supplement (branched-chain amino acids (BCAA) supplement)

Snippet

Sponsor: Mahidol University | Conditions: Decompensated Cirrhosis and Ascites | Phase 3 | Status: ENROLLING_BY_INVITATION